TY - JOUR
T1 - The impact of operational trial approaches on representativeness
T2 - Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice
AU - de Jong, Amos J.
AU - Zuidgeest, Mira G.P.
AU - Santa-Ana-Tellez, Yared
AU - Hallgreen, Christine E.
AU - van Sloten, Thomas T.
AU - de Boer, Anthonius
AU - Gardarsdottir, Helga
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/2
Y1 - 2025/2
N2 - Decentralized clinical trial (DCT) approaches – in which trial activities are conducted at participants’ homes – have the potential to improve representativeness. We present a study that compared the demographics and cardiovascular risk factors of participants from a DCT (ASCEND) and a conventional trial with a similar trial objective (POPADAD) to those of patients in daily practice. We adjudicate that there are relevant differences when comparing the participants of the conventional trial and the DCT, with the latter providing better representativeness in terms of age, insulin use, smoking status, and body mass index, whereas conventional trial participants were more representative in terms of biological sex. Differences in these characteristics were not explained by the eligibility criteria, but are considered attributable to the operational trial approach.
AB - Decentralized clinical trial (DCT) approaches – in which trial activities are conducted at participants’ homes – have the potential to improve representativeness. We present a study that compared the demographics and cardiovascular risk factors of participants from a DCT (ASCEND) and a conventional trial with a similar trial objective (POPADAD) to those of patients in daily practice. We adjudicate that there are relevant differences when comparing the participants of the conventional trial and the DCT, with the latter providing better representativeness in terms of age, insulin use, smoking status, and body mass index, whereas conventional trial participants were more representative in terms of biological sex. Differences in these characteristics were not explained by the eligibility criteria, but are considered attributable to the operational trial approach.
KW - clinical trial operations
KW - decentralized clinical trials
KW - generalizability
KW - participant representativeness
UR - http://www.scopus.com/inward/record.url?scp=85216928100&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2025.104304
DO - 10.1016/j.drudis.2025.104304
M3 - Review article
C2 - 39884338
AN - SCOPUS:85216928100
SN - 1359-6446
VL - 30
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 2
M1 - 104304
ER -